These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5301522)

  • 1. [Treatment of systemic lupus erythematosus with antimetabolites. Relations between the clinical course and immunological reactions].
    Cruchaud A; Pometta D; Rousso C
    Helv Med Acta; 1967; 34(1):Suppl:141-2. PubMed ID: 5301522
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of systemic lupus erythematosus with antimetabolites. Relations between the clinical course and immunological reactions].
    Cruchaud A; Pometta D; Rousso C
    Helv Med Acta Suppl; 1967 May; 47():141-2. PubMed ID: 5315493
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of systemic lupus erythematosus (SLE) with immunosuppressive drugs 1: An analysis of immunologic data.
    Cruchaud A; Pometta D; Rousso C
    Helv Med Acta; 1967 Dec; 34(1):5-22. PubMed ID: 4173836
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of systemic lupus erythematosus in childhood.
    Jacobs JC
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):304-7. PubMed ID: 318122
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunosuppressive therapy of systemic lupus erythematosus].
    Miescher PA; Lambert PH
    Ther Umsch; 1971 Sep; 28(9):579-85. PubMed ID: 5122520
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lupus erythematosus in childhood].
    Pulgram A; Zimprich H; Weippl G
    Wien Klin Wochenschr; 1973 Feb; 85(5):67-70. PubMed ID: 4685491
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoimmune disease.
    Mackay IR
    Med J Aust; 1969 Mar; 1(13):696-9. PubMed ID: 4890055
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive drug therapy of systemic lupus erythematosus.
    Fox DA; McCune WJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):265-99. PubMed ID: 8153402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of disseminated lupus erythematosus. So-called immunosuppressive drugs].
    Clément F
    Schweiz Med Wochenschr; 1970 Feb; 100(7):333-5. PubMed ID: 4189917
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lupus erythematosus, modern aspects (author's transl)].
    Canavese JC
    Schweiz Rundsch Med Prax; 1977 May; 66(19):565-72. PubMed ID: 69300
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic aspects of lupus erythematosus cells and antinuclear factors in disease states.
    Barnett EV
    Mayo Clin Proc; 1969 Sep; 44(9):645-8. PubMed ID: 4186061
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus.
    Aringer M; Steiner G; Graninger WB; Höfler E; Steiner CW; Smolen JS
    Arthritis Rheum; 2007 Jan; 56(1):274-9. PubMed ID: 17195231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic lupus erythematosus. Clinical, biological and immunological studies. (Report on 30 cases). II].
    Nouspikel P
    Praxis; 1968 Jun; 57(24):875-90. PubMed ID: 4888332
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppressive therapy in systemic lupus erythematosus].
    Deicher H
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):215-7. PubMed ID: 4538326
    [No Abstract]   [Full Text] [Related]  

  • 15. [2 cases of systemic lupus erythematosus treated with immunosuppressive agents].
    Laugier P; Hunziker N
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):410-1. PubMed ID: 5510737
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intervention of heparin in immunological phenomena: reversibility of the nuclear antigen and antinuclear antibody reaction in systemic lupus erythematosus].
    Bardare M; Menghi P
    Boll Soc Ital Biol Sper; 1965 Jul; 41(13):713-5. PubMed ID: 4164914
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
    Aringer M; Graninger WB; Steiner G; Smolen JS
    Arthritis Rheum; 2004 Oct; 50(10):3161-9. PubMed ID: 15476222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fluctuation of serum complement activities in systemic lupus erythematosus and its clinical significance].
    Okuda M
    Naika; 1970 Feb; 25(2):353-8. PubMed ID: 5309587
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
    [No Abstract]   [Full Text] [Related]  

  • 20. What's new in the treatment of pediatric SLE.
    Silverman E
    J Rheumatol; 1996 Sep; 23(9):1657-60. PubMed ID: 8877943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.